100 results on '"Westheim, Arne"'
Search Results
2. Einar Olav Rykke
3. The Role of Drug Therapy in Lowering Mortality and Morbidity: From Established Heart Failure to High-Risk Hypertension
4. ANTIHYPERTENSIVE TREATMENT IN PATIENTS WITH HEART FAILURE
5. Antihypertensive treatment in patients with heart failure
6. β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry
7. Medical Therapies for Heart Failure With Preserved Ejection Fraction
8. Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
9. Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
10. Knud Holck Landmark
11. Hjertesvikt med normal ejeksjonsfraksjon
12. ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
13. High cardiovascular risk profile in patients with sleep apnea
14. Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
15. Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
16. Baseline Anemia Is Not a Predictor of All-Cause Mortality in Outpatients With Advanced Heart Failure or Severe Renal Dysfunction
17. Inflammatory markers as related to disease severity in patients with chronic heart failure: Limited effects of exercise training
18. High Prevalence of Sleep Apnea in Heart Failure Outpatients: Even in Patients With Preserved Systolic Function
19. The role of beta-blockers in the treatment of chronic heart failure
20. Characteristics, Implementation of Evidence-Based Management and Outcome in Patients with Chronic Heart Failure Results from the Norwegian Heart Failure Registry
21. The L-Arginine–Asymmetric Dimethylarginine Ratio Is Strongly Related to the Severity of Chronic Heart Failure. No Effects of Exercise Training
22. Improved quality of life in Norwegian heart failure patients after follow‐up in outpatient heart failure clinics: results from the Norwegian heart failure registry
23. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure
24. Warning on Diuretic Use
25. Renal Function in Outpatients With Chronic Heart Failure
26. Impact of Systemic Hypertension on the Diagnostic Performance of B-Type Natriuretic Peptide in Patients With Acute Dyspnea
27. SERUM PHOSPHATE AND SYMPATHETIC TONE IN MILD ESSENTIAL HYPERTENSION
28. BLOOD PLATELET RELEASE CORRELATES WITH SERUM LIPIOS IN 50 YEAR OLD MEN WITH ESSENTIAL HYPERTENSION
29. EFFECT OF EXERCISE TRAINING IN PATIENTS WITH ESSENTIAL HYPERTENSION
30. Hemodynamic Effects at Rest and during Exercise in Long-term Treatment with Prazosin in Chronic Congestive Heart Failure
31. Long-Term Effects of a Group-Based High-Intensity Aerobic Interval-Training Program in Patients With Chronic Heart Failure
32. Pain and Quality of Life in Hospitalized Patients with Heart Failure
33. Effects of Group-Based High-Intensity Aerobic Interval Training in Patients With Chronic Heart Failure
34. Group-based Aerobic Interval Training in Patients With Chronic Heart Failure: Norwegian Ullevaal Model
35. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
36. Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty‐year follow‐up of middle‐aged men
37. Abstract 3794: Long-term Effects Of An Aerobic Training Program On Exercise Tolerance And Quality Of Life In Patients With Chronic Heart Failure. A Randomised Controlled Trial
38. The Antioxidative Effects of Long-Term Treatment Are More Pronounced for Carvedilol Than for Atenolol in Post-myocardial Infarction Patients
39. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
40. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure
41. The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials
42. N-Terminal pro-B-Type Natriuretic Peptide in Risk Stratification after Acute Myocardial Infarction in Patients on Long-Term Beta-Adrenergic Receptor Blocker Therapy
43. More heat to support aggressive blood pressure lowering: the FEVER study
44. B-Type Natriuretic Peptide Levels in Patients in the Emergency Department With Possible Heart Failure and Previous Stable Angina Pectoris and/or Healed Myocardial Infarction
45. Impact of Atrial Fibrillation on the Diagnostic Performance of B-Type Natriuretic Peptide Concentration in Dyspneic Patients
46. Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: Life, scope, and value
47. Predictors of Elevated B-Type Natriuretic Peptide Concentrations in Dyspneic Patients Without Heart Failure: An Analysis From the Breathing Not Properly Multinational Study
48. Insulin Sensitivity in Women with Coronary Heart Disease during Hormone Replacement Therapy
49. A Comparison of the Two β-Blockers Carvedilol and Atenolol on Left Ventricular Ejection Fraction and Clinical Endpoints after Myocardial Infarction
50. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.